New cancer clinical trial: Japan Phase 2 Study of Niraparib in Patients With Advanced, Relapsed Ovarian Cancer

Published on: November 30, 2018 at 12:00PM
Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Intervention:   Drug: Niraparib
Sponsor:   Takeda
Not yet recruiting
https://ift.tt/2QwNTww